Our data demonstrated hDT806 in both in vitro and in vivo settings can exploit tumor-intrinsic STING/IFN-I signaling to induce apoptosis and inhibit tumor cell growth in HNSCC. This evidence concerns the gene STING1 and head and neck squamous cell carcinoma.